Vaccines

All vaccines available in New Zealand are licensed for use in this country.

Vaccines on the New Zealand National Immunisation Schedule are free when given as part of the Schedule. Other vaccines are not funded, but are available for purchase through your family doctor.


The 2014 National Immunisation Schedule came into effect on 1 July 2014 and more recently, on 1 July 2015, eligibility for funded vaccines for some special groups was extended.
We are in the process of updating the eligibility information for Boostrix®, Infanrix®-hexa, Infanrix®-IPV, Prevenar 13®, Pneumovax® 23 and Varilrix®.

Schedule Vaccines

Act-HIB® is used for a booster vaccination at 15 months of age to protect against disease caused by Haemophilus influenzae type b. The...

ADT™ Booster is used for primary and booster vaccination of children 7 years of age and over and adults to protect against tetanus and diphtheria...

BCG vaccination for infants and children aged under 5 years at increased risk of exposure to tuberculosis (TB) has been temporarily suspended due...

Boostrix® is used to protect against diphtheria, tetanus and pertussis (whooping cough). 

Gardasil® protects against four types of human papillomavirus (HPV) infection. HPV types 6 and 11 cause anogenital warts and HPV types 16 and 18 ...

Havrix® is used to prevent infection with the hepatitis A virus.

HBvaxPRO® is used for primary vaccination of infants, children and adults to protect against the hepatitis B virus. HBvaxPRO® is also given to...

Infanrix®-hexa is used for primary and booster vaccination of infants and children to protect against diphtheria, tetanus, pertussis, hepatitis B...

Infanrix®-IPV is used for primary and booster vaccination of infants and children to protect against diphtheria, tetanus, pertussis and...

The influenza vaccine is given to protect against influenza in children older than six months of age and adults. The World Health Organization...

IPOL is used for primary and booster vaccination of infants, children and adults to protect against infection with Type 1, Type 2 and Type 3...

M-M-R® II is used for primary vaccination and revaccination of children and adults to protect against measles, mumps and rubella.

Menactra® is a meningococcal A,C,Y,W-135 conjugate vaccine used to protect against four groups of Neisseria meningitidis, group A...

NeisVac-C® is a meningococcal C conjugate vaccine used to protect against Neisseria meningitidis group C only.

The conjugate and...

Pneumovax® 23 is used to protect against disease caused by 23 types of Streptococcus pneumoniae.

Prevenar 13® is used to protect against disease caused by 13 types of Streptococcus pneumoniae

RotaTeq® is an immunisation given to infants by mouth (orally) to protect them from severe rotavirus infection. RotaTeq® is free on the National...

Synflorix® is used for primary and booster vaccination of infants and children up to their 5th birthday to protect against disease caused by 10...

Varilrix® is used for primary vaccination of infants from nine months of age, children and adults to protect against varicella-zoster infection (...

Other Vaccines

Adacel® is a privately purchased vaccine that protects against tetanus, diphtheria and whooping cough.

Avaxim® is used to prevent infection with the hepatitis A virus.

Engerix®-B is a privately purchased vaccine to protect against hepatitis B for adolescents aged 18 years and over and adults who do not meet the eligibility criteria for funded HBvaxPRO®.

Supply of Mencevax® ACWY has been discontinued in New Zealand. Menactra® and Nimenrix® are alternative vaccine brands.

Supply of Meningitec® has been discontinued in New Zealand. NeisVac-C®, Menactra® and Nimenrix® are alternative vaccine brands.

There are no supplies of Menomune® currently in New Zealand. Menactra® and Nimenrix® are alternative vaccine brands.

Nimenrix® is a meningococcal A,C,Y,W-135 conjugate vaccine used to protect against four groups of Neisseria meningitidis, group A, group C, group Y and group W-135.

Varivax® is used for primary vaccination of children from 12 months of age and adults to protect against varicella-zoster infection (chickenpox).

Zostavax® is used to prevent the occurrence of herpes zoster (shingles) in adults aged 50 years and older.